Effect of short-term exposure to dichlorvos on synaptic plasticity of rat hippocampal slices: Involvement of acylpeptide hydrolase and α7 nicotinic receptors

Toxicology and Applied Pharmacology

Volumn 238, Issue 1, 2009, Pages 37-46

  Olmos, Cristina ^a   Sandoval, Rodrigo ^a   Rozas, Carlos ^b   Navarro, Sebastián ^a   Wyneken, Ursula ^c   Zeise, Marc ^d   Morales, Bernardo ^b   Pancetti, Floria ^a  

^a Faculty of Medicine   (Chile)

^b Laboratory of Neurosciences   (Chile)

^c UNIVERSIDAD DE LOS ANDES   (Chile)

^d UNIVERSIDAD DE SANTIAGO DE CHILE   (Chile)

Author keywords

Acylpeptide hydrolase; Dichlorvos; Hippocampus; Nicotinic receptors; Synaptic plasticity

Indexed keywords

ACYLAMINO ACID RELEASING ENZYME; BUNGAROTOXIN RECEPTOR; BUNGAROTOXIN RECEPTOR ANTAGONIST; CHOLINESTERASE INHIBITOR; DICHLORVOS; METHYLLICACONITINE; METRIFONATE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; COGNITIVE DEFECT; CONTROLLED STUDY; ENZYME INHIBITION; HIPPOCAMPUS; INTERNEURON; LONG TERM POTENTIATION; NERVE CELL PLASTICITY; NONHUMAN; RAT;

ANIMALS; CHOLINESTERASE INHIBITORS; DICHLORVOS; HIPPOCAMPUS; NEURONAL PLASTICITY; PEPTIDE HYDROLASES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC; SYNAPSES; TIME FACTORS;

RATTUS;

EID: 66049107577     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2009.04.011     Document Type: Article

References (55)

1. Alkondon M., and Albuquerque E.X. The nicotinic acetylcholine receptor subtypes and their function in the hippocampus and cerebral cortex. Prog. Brain Res. 145 (2004) 109-120
2. Bear M.F., and Malenka R.C. Synaptic plasticity: LTP and LTD. Curr. Opin. Neurobiol. 4 (1994) 389-399
3. Bliss T.V., and Lomo T. Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J. Physiol. 232 (1973) 331-356
4. Buccafusco J.J., and Terry Jr. A.V. Multiple central nervous system targets for eliciting beneficial effects on memory and cognition. J. Pharmacol. Exp. Ther. 295 (2000) 438-446
5. Carter W.G., Tarhoni M., Rathbone A.J., and Ray D.E. Differential protein adduction by seven organophosphorus pesticides in both brain and thymus. Hum. Exp. Toxicol. 26 (2007) 347-353
6. Chen L., Yamada K., Nabeshima T., and Sokabe M. alpha7 Nicotinic acetylcholine receptor as a target to rescue deficit in hippocampal LTP induction in beta-amyloid infused rats. Neuropharmacology 50 (2006) 254-268
7. Choudhary S., Joshi K., and Gill K.D. Possible role of enhanced microtubule phosphorylation in dichlorvos induced delayed neurotoxicity in rat. Brain Res. 897 (2001) 60-70
8. Duysen E.G., Li B., Xie W., Schopfer L.M., Anderson R.S., Broomfield C.A., and Lockridge O. Evidence for nonacetylcholinesterase targets of organophosphorus nerve agent: supersensitivity of acetylcholinesterase knockout mouse to VX lethality. J. Pharmacol. Exp. Ther. 299 (2001) 528-535
9. Ellman G.L., Courtney K.D., Andres Jr. V., and Feather-Stone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7 (1961) 88-95
10. Espinoza-Fonseca L.M. Molecular docking of four beta-amyloid1-42 fragments on the alpha7 nicotinic receptor: delineating the binding site of the Abeta peptides. Biochem. Biophys. Res. Commun. 323 (2004) 1191-1196
11. Fabian-Fine R., Skehel P., Errington M.L., Davies H.A., Sher E., Stewart M.G., and Fine A. Ultrastructural distribution of the alpha7 nicotinic acetylcholine receptor subunit in rat hippocampus. J. Neurosci. 21 (2001) 7993-8003
12. Freedman R., Hall M., Adler L.E., and Leonard S. Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biol. Psychiatry 38 (1995) 22-33
13. Freedman R., Coon H., Myles-Worsley M., Orr-Urtreger A., Olincy A., Davis A., Polymeropoulos M., Holik J., Hopkins J., Hoff M., Rosenthal J., Waldo M.C., Reimherr F., Wender P., Yaw J., Young D.A., Breese C.R., Adams C., Patterson D., Adler L.E., Kruglyak L., Leonard S., and Byerley W. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 587-592
14. Fujii S., and Sumikawa K. Acute and chronic nicotine exposure reverse age-related declines in the induction of long-term potentiation in the rat hippocampus. Brain Res. 894 (2001) 347-353
15. Greenfield S.A., Day T., Mann E.O., and Bermudez I. A novel peptide modulates alpha7 nicotinic receptor responses: implications for a possible trophic-toxic mechanism within the brain. J. Neurochem. 90 (2004) 325-331
16. Guan X., Nakauchi S., and Sumikawa K. Nicotine reverses consolidated long-term potentiation in the hippocampal CA1 region. Brain Res. 1078 (2006) 80-91
17. Higgins M.J., and Stone T.W. Bicuculline-resistant paired-pulse inhibition in the rat hippocampal slice. Br. J. Pharmacol. 109 (1993) 1164-1168
18. Hinz V.C., Grewig S., and Schmidt B.H. Metrifonate induces cholinesterase inhibition exclusively via slow release of dichlorvos. Neurochem. Res. 21 (1996) 331-337
19. Ivens I.A., Schmuck G., and Machemer L. Learning and memory of rats after long-term administration of low doses of parathion. Toxicol. Sci. 46 (1998) 101-111
20. Ji D., Lape R., and Dani J.A. Timing and location of nicotinic activity enhances or depresses hippocampal synaptic plasticity. Neuron 31 (2001) 131-141
21. Jones W.M., and Manning J.M. Acylpeptide hydrolase activity from erythrocytes. Biochem. Biophys. Res. Commun. 126 (1985) 933-940
22. Klein R.C., and Yakel J.L. Inhibition of nicotinic acetylcholine receptors by apolipoprotein E-derived peptides in rat hippocampal slices. Neuroscience 127 (2004) 563-567
23. Kleschevnikov A.M., Sokolov M.V., Kuhnt U., Dawe G.S., Stephenson J.D., and Voronin L.L. Changes in paired-pulse facilitation correlate with induction of long-term potentiation in area CA1 of rat hippocampal slices. Neuroscience 76 (1997) 829-843
24. Levy R.B., and Aoki C. Alpha7 nicotinic acetylcholine receptors occur at postsynaptic densities of AMPA receptor-positive and -negative excitatory synapses in rat sensory cortex. J. Neurosci. 22 (2002) 5001-5015
25. Lopez-Arrieta J.M., and Schneider L. Metrifonate for Alzheimer's disease. Cochrane Database Syst. Rev. (2006). http://DOI:10.1002/14651858.CD003155.pub3 Issue 2. Art. N° CD003155. DOI:10.1002/14651858.CD003155.pub3
26. Maelicke A., Schrattenholz A., Samochocki M., Radina M., and Albuquerque E.X. Allosterically potentiating ligands of nicotinic receptors as a treatment strategy for Alzheimer's disease. Behav. Brain Res. 113 (2000) 199-206
27. McGehee D.S. Molecular diversity of neuronal nicotinic acetylcholine receptors. Ann. N.Y. Acad. Sci. 868 (1999) 565-577
28. Megias M., Emri Z., Freund T.F., and Gulyas A.I. Total number and distribution of inhibitory and excitatory synapses on hippocampal CA1 pyramidal cells. Neuroscience 102 (2001) 527-540
29. Morris J.C., Cyrus P.A., Orazem J., Mas J., Bieber F., Ruzicka B.B., and Gulanski B. Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease. Neurology 50 (1998) 1222-1230
30. Perrier J., Giardina T., Durand A., and Puigserver A. Specific enhancement of acylase I and acylpeptide hydrolase activities by the corresponding N-acetylated substrates in primary rat hepatocyte cultures. Biol. Cell 94 (2002) 45-54
31. Pettit D.L., Shao Z., and Yakel J.L. beta-Amyloid(1-42) peptide directly modulates nicotinic receptors in the rat hippocampal slice. J. Neurosci. 21 (2001) RC120
32. Polgar L. The prolyl oligopeptidase family. Cell. Mol. Life Sci. 59 (2002) 349-362
33. Ray D.E., and Richards P.G. The potential for toxic effects of chronic, low-dose exposure to organophosphates. Toxicol. Lett. 120 (2001) 343-351
34. Richards P.G., Johnson M.K., and Ray D.E. Identification of acylpeptide hydrolase as a sensitive site for reaction with organophosphorus compounds and a potential target for cognitive enhancing drugs. Mol. Pharmacol. 58 (2000) 577-583
35. Ringman J.M., and Cummings J.L. Metrifonate: update on a new antidementia agent. J. Clin. Psychiatry 60 (1999) 776-782
36. Rosenblum J.S., and Kozarich J.W. Prolyl peptidases: a serine protease subfamily with high potential for drug discovery. Curr. Opin. Chem. Biol. 7 (2003) 496-504
37. Sarin S., and Gill K.D. Biochemical and behavioral deficits in adult rat following chronic dichlorovos exposure. Pharmacol. Biochem. Behav. 59 (1998) 1081-1086
38. Scaloni A., Jones W.M., Barra D., Pospischil M., Sassa S., Popowicz A., Manning L.R., Schneewind O., and Manning J.M. Acylpeptide hydrolase: inhibitors and some active site residues of the human enzyme. J. Biol. Chem. 267 (1992) 3811-3818
39. Seguela P., Wadiche J., Dineley-Miller K., Dani J.A., and Patrick J.W. Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium. J. Neurosci. 13 (1993) 596-604
40. Senthilkumar R., Reddy P.N., and Sharma K.K. Studies on trypsin-modified bovine and human lens acylpeptide hydrolase. Exp. Eye Res. 72 (2001) 301-310
41. Sharma K.K., and Kester K. Peptide hydrolysis in lens: role of leucine aminopeptidase, aminopeptidase III, prolyloligopeptidase and acylpeptidehydrolase. Curr. Eye Res. 15 (1996) 363-369
42. Smulders C.J., Bueters T.J., Vailati S., van Kleef R.G., and Vijverberg H.P. Block of neuronal nicotinic acetylcholine receptors by organophosphate insecticides. Toxicol. Sci. 82 (2004) 545-554
43. Smulders C.J., Zwart R., Bermudez I., van Kleef R.G., Groot-Kormelink P.J., and Vijverberg H.P. Cholinergic drugs potentiate human nicotinic alpha4beta2 acetylcholine receptors by a competitive mechanism. Eur. J. Pharmacol. 509 (2005) 97-108
44. Terry Jr. A.V., and Buccafusco J.J. The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development. J. Pharmacol. Exp. Ther. 306 (2003) 821-827
45. Timmermann D.B., Gronlien J.H., Kohlhaas K.L., Nielsen E.O., Dam E., Jorgensen T.D., Ahring P.K., Peters D., Holst D., Chrsitensen J.K., Malysz J., Briggs C.A., Gopalakrishnan M., and Olsen G.M. An allosteric modulator of the alpha7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivo. J. Pharmacol. Exp. Ther. 323 (2007) 294-307
46. Van der Staay F.J., Hinz V.C.H., and Schmidt B.H. Effects of metrifonate, its transformation product dichlorvos, and other organophosphorus and reference cholinesterase inhibitors on Morris water escape behaviour in young-adult rats. J. Pharmacol. Exp. Ther. 278 (1996) 697-708
47. Wanaverbecq N., Semyanov A., Pavlov I., Walker M.C., and Kullmann D.M. Cholinergic axons modulate GABAergic signaling among hippocampal interneurons via postsynaptic alpha 7 nicotinic receptors. J. Neurosci. 27 (2007) 5683-5693
48. Wang H.Y., Lee D.H., D'Andrea M.R., Peterson P.A., Shank R.P., and Reitz A.B. beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology. J. Biol. Chem. 275 (2000) 5626-5632
49. Wang H.Y., Lee D.H., Davis C.B., and Shank R.P. Amyloid peptide Abeta(1-42) binds selectively and with picomolar affinity to alpha7 nicotinic acetylcholine receptors. J. Neurochem. 75 (2000) 1155-1161
50. Whitlock J.R., Heynen A.J., Shuler M.G., and Bear M.F. Learning induces long-term potentiation in the hippocampus. Science 313 (2006) 1093-1097
51. Williams B.R. Metrifonate: a new agent for the treatment of Alzheimer's disease. Am. J. Health Syst. Pharm. 56 (1999) 427-432
52. Xie W., Stribley J.A., Chatonnet A., Wilder P.J., Rizzino A., McComb R.D., Taylor P., Hinrichs S.H., and Lockridge O. Postnatal developmental delay and supersensitivity to organophosphate in gene-targeted mice lacking acetylcholinesterase. J. Pharmacol. Exp. Ther. 293 (2000) 896-902
53. Yamin R., Bagchi S., Hildebrant R., Scaloni A., Widom R.L., and Abraham C.R. Acyl peptide hydrolase, a serine proteinase isolated from conditioned medium of neuroblastoma cells, degrades the amyloid-beta peptide. J. Neurochem. 100 (2007) 458-467
54. Yankner B.A., Duffy L.K., and Kirschner D.A. Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science 250 (1990) 279-282
55. Zbarsky V., Thomas J., and Greenfield S. Bioactivity of a peptide derived from acetylcholinesterase: involvement of an ivermectin-sensitive site on the alpha 7 nicotinic receptor. Neurobiol. Dis. 16 (2004) 283-289